Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05693701 · ClinicalTrials.gov registry record · NA
Multicomponent Intervention Study- Blood Donors With High Cholesterol
A NA study of Lipid Metabolism Disorder, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05693701: Recruiting NA study of Lipid Metabolism Disorder, sponsored by University of Texas Southwestern Medical Center.
NCT05693701 is a NA study of Lipid Metabolism Disorder that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05693701, a NA study of Lipid Metabolism Disorder, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).
Primary Outcome
This is the difference between the two study arms in change in LDL cholesterol level measurements obtained from lab work of blood samples from baseline and at 6 months
Conditions Studied
Interventions
- BEHAVIORAL Implementation Strategy Bundle
- OTHER Usual care notification
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-02-27 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What NCT05693701 shows while recruiting
NCT05693701 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Lipid Metabolism Disorder appearing as the primary indexed condition, and to 2 interventions - of which Implementation Strategy Bundle is the first listed.
NCT05693701 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05693701 about?
NCT05693701 is a clinical study titled "Multicomponent Intervention Study- Blood Donors With High Cholesterol". The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).
What is the current status of trial NCT05693701?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-02-27. Estimated completion is 2027-04-30.
What conditions does trial NCT05693701 study?
This clinical trial studies the following conditions: Lipid Metabolism Disorder.
What interventions are being tested in trial NCT05693701?
The interventions under investigation include: Implementation Strategy Bundle (BEHAVIORAL), Usual care notification (OTHER).
Who is sponsoring clinical trial NCT05693701?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05693701 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lipid Metabolism Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05693701's enrollment target sits among peer trials
100 841st of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI